|
TMTC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.627600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.546000E-02 |
| Normal-vs-Stage2 |
4.237800E-02 |
| Normal-vs-Stage3 |
3.330400E-02 |
| Normal-vs-Stage4 |
1.576850E-03 |
| Stage1-vs-Stage2 |
5.128400E-01 |
| Stage1-vs-Stage3 |
4.631600E-01 |
| Stage1-vs-Stage4 |
3.986100E-02 |
| Stage2-vs-Stage3 |
9.248600E-01 |
| Stage2-vs-Stage4 |
3.490400E-01 |
| Stage3-vs-Stage4 |
2.328600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.121900E-02 |
| Normal-vs-AfricanAmerican |
6.319400E-01 |
| Normal-vs-Asian |
1.315570E-02 |
| Caucasian-vs-AfricanAmerican |
3.558000E-01 |
| Caucasian-vs-Asian |
3.558200E-01 |
| AfricanAmerican-vs-Asian |
1.490020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.635300E-03 |
| Normal-vs-Female |
4.911700E-02 |
| Male-vs-Female |
3.993600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.050400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.759300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.745700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.002400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.516000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.231600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.599600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.364400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.594000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.998200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.866000E-01 |
| Classical-VS-Follicular |
1.605780E-02 |
| Classical-VS-Other |
1.090240E-01 |
| Classical-VS-Normal |
1.546170E-01 |
| Tall-VS-Follicular |
4.704600E-01 |
| Tall-VS-Other |
3.045600E-01 |
| Tall-VS-Normal |
1.400370E-01 |
| Follicular-VS-Other |
4.628400E-01 |
| Follicular-VS-Normal |
4.979000E-03 |
| Other-VS-Normal |
2.841900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.698400E-03 |
| Normal-vs-N1 |
2.760400E-02 |
| N0-vs-N1 |
8.093600E-01 |
|
|
